<h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Interim marketing authorization</h6><ul class="ProvisionList"><li><p class="Subsection transitional&#xA;        "><strong><a id="s-417."><span class="sectionLabel">417.</span></a></strong> (1) An interim marketing authorization that is issued under subsection 30.2(1) of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite> and in effect immediately before the day on which section 416 comes into force continues to have effect until the earliest of</p><ul class="ProvisionList"><li><p class="Paragraph transitional&#xA;        ">(<em>a</em>) the day on which the Minister of Health publishes a notice cancelling the interim marketing authorization in the <cite class="XRefExternal"><a href="http://www.gazette.gc.ca/">Canada Gazette</a></cite>;</p></li><li><p class="Paragraph transitional&#xA;        ">(<em>b</em>) the day on which a marketing authorization — or any part of it — that is issued under subsection 30.3(1) of the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>, as enacted by section 416, has the same effect as the interim marketing authorization; and</p></li><li><p class="Paragraph transitional&#xA;        ">(<em>c</em>) two years after the day on which the interim marketing authorization is published in the <cite class="XRefExternal"><a href="http://www.gazette.gc.ca/">Canada Gazette</a></cite>.</p></li></ul></li><li><h6 class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Exemption from <cite class="XRefExternalAct"><a href="/eng/acts/S-22">Statutory Instruments Act</a></cite></h6><p class="Subsection transitional&#xA;        ">(2) A notice cancelling an interim marketing authorization is exempt from sections 3, 5 and 11 of the <cite class="XRefExternalAct"><a href="/eng/acts/S-22">Statutory Instruments Act</a></cite>.</p></li></ul>
